Clinical trial
The Optimised Use of Romozosumab Study
NCT06059222 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Optimised Use of Romozosumab Study
- Lead sponsor
- University of Aarhus
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- October 2, 2023
- Completion date
- August 31, 2032
- Enrollment
- 270 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.